West Pharmaceutical Services Inc
WST- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000105770
In the last 90 days, West Pharmaceutical Services Inc insiders filed 0 open-market purchases and 2 sales; 834 institutions reported holding it in 13F filings for Q2 2026, worth $25.2B in total; Gates Foundation Trust is the only superinvestor holding it.
13F holders, Q3 2023
Institutional positions in West Pharmaceutical Services Inc as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 759
- +33 vs. Q2 2023
- Shares held
- 68.4M
- +357.3K (+0.5%) vs. Q2 2023
- Total value
- $25.8B
- −$173.4M (−0.7%) vs. Q2 2023
- New holders
- 83
- 243 more added
- Sold out
- 50
- 303 more reduced
9 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting WST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 834 | $25.2B |
| Q1 2026 | 755 | $17.8B |
| Q4 2025 | 804 | $19.1B |
| Q3 2025 | 758 | $18.0B |
| Q2 2025 | 733 | $15.3B |
| Q1 2025 | 715 | $15.6B |
| Q4 2024 | 747 | $22.9B |
| Q3 2024 | 733 | $20.5B |
| Q2 2024 | 778 | $22.4B |
| Q1 2024 | 778 | $27.0B |
| Q4 2023 | 784 | $24.1B |
| Q3 2023 | 759 | $25.8B |
| Q2 2023 | 735 | $26.0B |
| Q1 2023 | 698 | $24.0B |
| Q4 2022 | 638 | $16.3B |
| Q3 2022 | 638 | $16.9B |
| Q2 2022 | 657 | $20.6B |
| Q1 2022 | 718 | $28.2B |
| Q4 2021 | 731 | $32.2B |
| Q3 2021 | 672 | $28.5B |
| Q2 2021 | 641 | $24.7B |
| Q1 2021 | 591 | $19.3B |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding West Pharmaceutical Services Inc; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CVA Family Office, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Disciplined Investments, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Bollard Group LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| SkyView Investment Advisors, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Crewe Advisors LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| 1832 Asset Management L.P. | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Fiduciary Alliance LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Motco | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| iA Global Asset Management Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Kistler-Tiffany Companies, LLC | – | – | – | – | Not filed |
| Pictet Asset Management SA | – | – | – | – | Not filed |
| Tekla Capital Management LLC | – | – | – | – | Not filed |
| Tiaa, FSB | – | – | – | – | Not filed |
| Lumature Wealth Partners, LLC | – | – | – | – | Not filed |
| Endurance Wealth Management, Inc. | – | – | – | – | Not filed |
| EA Series Trust | – | – | – | – | Not filed |
| BerganKDV Wealth Management, LLC | – | – | – | – | Not filed |
| First Capital Advisors Group, LLC. | – | – | – | – | Not filed |